Pharmacokinetics and relative bioavailability of domestic vs imported cefpodoxime proxetil tablets in human body

申屠建中,倪力强,陈志根,章霞,吴丽花,汪涛,卢晓阳
DOI: https://doi.org/10.3969/j.issn.1007-7669.2004.11.002
2004-01-01
Abstract:AIM: To compare pharmacokinetics and the relative bioavailability of domestic and imported cefpodoxime proxetil tablets in normal human body. METHODS: A single oral domestic cefpodoxime proxetil tablet or imported tablet 200 mg was given to 24 healthy male volunteers in randomized self-crossover study. Plasma concentration of cefpodoxime was measured by reverse phase high performance liquid chromatography. The pharmacokinetic parameters as well as relative bioavailability were measured by 3P97. RESULTS: The concentration-time curves of domestic cefpodoxime proxetil tablet conformed to one compartment open model. The T maxwere ( 2.5± s0.6) h and ( 2.3 ±0.5) h,C max( 3.5 ±0.6) mg·L -1and( 3.6 ±0.5) mg·L -1,AUC 0-t(18±3) mg·L -1and (18.0 ±2.8) mg·L -1,AUC 0-∞(19±3) mg·L -1and (19±3) mg·L -1,T 12Ke( 2.0 ±0.3) hand ( 2.2± 0.4) h, respectively. The relative bioavailability of domestic cefpodoxime proxetil tablet was (102±15)% compared with imported cefpodoxime proxetil tablet. CONCLUSION: The results of the statistical analysis shows that the two kinds of tablets are bioequivalent.
What problem does this paper attempt to address?